新西伯利亚国立大学（Novosibirsk State University） 生物有机化学  博士

新西伯利亚国立大学（Novosibirsk State University） 分子生物学  硕士

黑龙江大学  生物技术与俄语文学  双学士学位

大脑是人体最复杂的器官，然而血脑屏障的存在使得超过98%的小分子药物和几乎全部大分子药物难以在脑部达到有效治疗浓度，中枢神经系统疾病长期面临药物递送效率低下的关键瓶颈。本人聚焦脑部精准给药这一核心命题，致力于开发可高效穿透血脑屏障的多功能药物递送平台，涵盖蛋白纳米载体设计、含硼诊疗分子构建及双模态成像引导等关键技术，推动化疗、BNCT协同治疗及新型抗菌药物脑部递送等多场景应用，为脑部恶性肿瘤、耐药性中枢感染及其他血脑屏障相关脑部疾病的精准治疗提供全新策略。

1. 俄罗斯科学基金委员会，俄罗斯科学基金项目，19-74-20123，基于治疗性核苷酸和人血清白蛋白偶联物的多功能含硼纳米结构用于恶性肿瘤的成像和治疗，2019-2023，2400万卢布，结题，项目骨干

2. 横向项目，苏州健华制药×俄罗斯科学院，No. 24.01.22-LORS，国际合作项目-双模态靶向抗癌偶联药物合成与活性验证，2021-2023，40万元，结题，项目负责人

3. 俄罗斯联邦基础科学部，国家重大课题项目，121031300042-1，智能生物医学材料，2021-2024，1518.5万卢布，结题，子课题参与

4. 福建省自然科学基金委员会，福建省杰出青年项目，2025J010046，异种免疫调控机制解析及新型异种器官移植供体构建，2025-2028，40 万元，参与

5. 福耀科技大学校级科研项目，34/PF2025-H07，用于耐药性颅内感染的多模态可视化白蛋白-抗菌剂诊疗药物开发与临床前研究，2026-01 至 2028-12，15万元，在研，主持

6. 福建省科学技术厅，福建省育成项目，重塑"冷"肿瘤：智能脑靶向递药系统协同免疫激活与化疗抗胶质瘤研究，2026-09 至 2028-08，3万元，在研，主持

1. T. V. Popova; Wang M; T. N. Kurochkin; S. A. Tsyrempilov; O. D. Zakharova; V. N. Silnikov; T. S. Godovikova ; Preparation of Boron-Containing S-Nitrosothiol Based on Homocysteinylamides of Human Serum Albumin for Combined NO-Chemical and Boron-Neutron-Capture Therapy. Russian Journal of Bioorganic Chemistry, 2025, 51: 202-215

2. Wang M; S. A. Tsyrempilov; I. A. Moskalev; O. D. Zakharova; A. I. Kasatova; V. N. Silnikov; T. S. Godovikova; T. V. Popova ; Chemotherapeutic Boron-containing Homocysteinamides of Human Serum Albumin. Russian Journal of Bioorganic Chemistry, 2025, 51(1): 354-371

3. Avramchuk Tatyana Vitalievna； Wang M; Zakharova Olga Dmitrievna； Godovikova Tatyana Sergeevna； Silnikov Vladimir Nikolaevich；   Antitumor conjugate based on human serum albumin for imaging and combination therapy of glioblastoma. RU2835210，2025

4. Wang M; Rogaleva V. I.; Popova T. V.; Zakharova O. D.; Godovikova T. S.; Silnikov V. N. ; In vitro Effect of the Homocysteine Linker on Properties of Conjugates between Human Serum Albumin and Monomethyl Auristatin F. Chemistry for Sustainable Development, 2024, 32: 750-759

5. Wang M; Ivan A. Moskalev; Olga D. Zakharova; Anna I. Kasatova; Vladimir N. Silnikov; Tatyana V. Popova; Tatyana S. Godovikova ; Development of theranostics albumin auristatin conjugates for combining chemotherapy with boron neutron capture therapy. Journal of Biology and Today's World, 2024, 13(01): 000-007  

6. Valeria I. Raskolupova; Wang M; Maya A. Dymova; Gleb O. Petrov; Ivan M. Shchudlo; Sergey Yu. Taskaev; Tatyana V. Abramova; Tatyana S. Godovikova; Vladimir N. Silnikov; Tatyana V. Popova ; Design of the New Closo-Dodecarborate-Containing Gemcitabine Analogue for the Albumin Based Theranostics Composition. Molecules, 2023, 28: 2672

7. Wang M, Rogaleva V.I., Zakharova O.D., Dymova M.A., Silnikov V.N., Godovikova T.S., Avramchuk T.V. Development of boron-containing multifunctional nanostructures based on modified forms of albumin for theranostics of malignant tumors. V All-Russian Conference «Physicochemical Biology». (2024)Russia

8. Wang M, Rogaleva V.I., Kasatova A.I., Zakharova O.D., Avramchuk T.V. Development of albumin-based theranostic conjugates for combining chemotherapy with boron-neutron capture therapy. 5 th All-Russian School of Young Scientists on BNCT. 5 th All-Russian School of Young Scientists on BNCT. (2023)Russia

9. Wang M, Olga Zakharova, Tatyana Avramchuk. Development of albumin-based theranostic conjugates for combining chemotherapy with boron neutron capture therapy. Bio-Top 2023. (2023) Russia

10. Silnikov V.N., Avramchuk T.V., Wang M, Abramova T.V., Raskolupova V.I., Taskaev S.Yu., Dymova M.A., Zakharova O.D., Godovikova T.S. Human serum albumin is a universal platform for the creation of theranostics for BNCT. All-Russian Conference «Synthetic biology and biopharmaceuticals». (2022) Russia

11. Alesya Fokina, Wang M, Anna Ilyina, Kristina Klabenkova, Ekaterina Burakova, Boris Chelobanov, Dmitry Stetsenko. Analysis of new charge-neutral DNA/RNA analogues phosphoryl guanidine oligonucleotides (PGO) by gel electrophoresis. Analytical Biochemistry, 2018, 555:9-11